Medicenna Therapeutics Corp. — Form D
Medicenna Therapeutics Corp. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-06. The offering totals $2.3M, of which $253K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-07-06
- Form: D
- Accession: 0001807983-26-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $253K
- Remaining: $2.1M
- Investors: 3
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-589660
Issuer
- Name: Medicenna Therapeutics Corp.
- CIK: 0001807983
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2015
- Address: 2 BLOOR STREET W SUITE 903, TORONTO, A6, M4W 3E2
- Phone: 604-671-6673
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Albert G. Beraldo | Related Person | Toronto, A6 |
| John Geltosky | Related Person | Toronto, A6 |
| Angelos Georgakis | Related Person | Toronto, A6 |
| David Hyman | Related Person | Toronto, A6 |
| Nageatte Ibrahim | Related Person | Toronto, A6 |
| Karim Lalji | Related Person | Toronto, A6 |
| Fahar Merchant | Related Person | Toronto, A6 |
| Rosemina Merchant | Related Person | Toronto, A6 |
| Richard Sutin | Related Person | Toronto, A6 |
| David Hyman | Executive Officer | Toronto, A6 |
| Elizabeth Williams | Executive Officer | Croton on Hudson, NY |
| John Sampson | Director | Toronto, A6 |
| Rosemina Merchant | Executive Officer | Toronto, A6 |
| Karen Dawes | Director | Toronto, A6 |
| Albert Beraldo | Director | Toronto, A6 |
| Fahar Merchant | Director | Toronto, A6 |
| Fahar Merchant | Executive Officer | Toronto, A6 |
| John Geltosky | Director | Toronto, A6 |
| KAREN G DAWES | Director | TORONTO, A6 |
| ALBERT G BERALDO | Director | TORONTO, A6 |
| ANDREW G STRONG | Director | TORONTO, A6 |
| CHANDRA PANCHAL | Director | TORONTO, A6 |
| ROSEMINA G MERCHANT | Director | TORONTO, A6 |
Other filings by this issuer (3)
More